Investigational new drugThyroid Analog
Compound 61534
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061534
Risk Class
MODERATE
Last Audit
Mar 28, 2108
Research Abstract
Thyroid Analog candidate engineered for cellular repair initiatives with automated dossier coverage.
Compound 61534 is a thyroid analog asset inside thyroid analog innovation track initiatives, optimized for cellular repair and tissue regeneration.
The dossier currently sits in investigational new drug with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061534 with updates logged 2108-03-28.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cellular repairTissue regeneration
Nomenclature
CX-61534Thyroid Analog Program 61534
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061534
- [2] Operations Pulse • Thyroid Analog innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61534